BIIE-0246
N/A
Report date: 2025/01/26 16:20:35
NME
Base Information
Drug NameBIIE-0246
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBoehringer Ingelheim International Gmbh
China Registration ClassN/A
Develop Information
Active CompaniesBoehringer Ingelheim International Gmbh
Inactive CompaniesThe Scripps Research Institute IncKarolinska Institutet
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A